Jennifer L. McNeer to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Jennifer L. McNeer has written about Antineoplastic Agents, Immunological.
Connection Strength
0.733
-
How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S8-S11.
Score: 0.549
-
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2025 Feb 27; 392(9):875-891.
Score: 0.184